Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Endometrial Neoplasms 4Uterine Cervical Neoplasms 2Uterine Prolapse 1Uterine Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Precancerous Conditions 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Obesity, Morbid 1Menstruation Disturbances 1Lung Neoplasms 1Leiomyoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Genital Diseases, Female 1Esophageal Neoplasms 1Endometriosis 1Adenomyosis 1

Interventions

cetrorelix 1Triptorelin Pamoate 1Sutures 1Rocuronium 1Robotic Surgical Procedures 1Radiotherapy 1Radiation 1Menotropins 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Hysterectomy 1Gonadotropins 1Endoscopes 1Electrocoagulation 1Danazol 1Chorionic Gonadotropin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometriosis × Robotic Surgical Procedures × Gynecologic × Clear all
NCT07120945 2026-06-02

Embrace Gyn

Medtronic - MITG

Phase NA Active not recruiting
70 enrolled
GynecologicOther neoplasm

Uterine Cervical Neoplasms, Endometriosis, Leiomyoma, Menstruation Disturbances, Ovarian Neoplasms, Precancerous Conditions, Uterine Prolapse, Endometrial Neoplasms, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡